Global Rosuvastatin Market Professional Survey Report 2016

This report
Mainly covers the following product types
Injection
Freeze-dried powder
The segment applications including
Hospital use
Clinic
Others
Segment regions including (the separated region report can also be offered)
USA
China
UK
France
Switzerland
Japan
Germany
Canada
The players list (Partly, Players you are interested in can also be added)
Pfizer
Teva
AstraZeneca UK Limited
Novartis
Mylan
Squibb
Sandoz
Hikma Pharmaceuticals?
GSK
Johnlee Pharmaceuticals Pvt. Ltd
Glenmark
Abbott
Takeda
IPR Pharmaceuticals
Lunan Better Pharmaceutical Co., Ltd
Nanjing Chia Tai Tianqing
Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd.
Zhejiang Jingxin Pharmaceutical
Zhejiang Haizheng
Hainan Tongyong Sanyang
Indian Biocon
With no less than 15 top producers.

Data including (both global and regions): Market Size (both volume - Box and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Box, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

Table of Contents

1 Industry Overview of Rosuvastatin
1.1 Definition and Specifications of Rosuvastatin
1.1.1 Definition of Rosuvastatin
1.1.2 Specifications of Rosuvastatin
1.1.2.1 5mg/Pill
1.1.2.2 10mg/Pill
1.1.2.3 20/Pill
1.1.2.4 Others
1.2 Classification of Rosuvastatin
1.2.1 Injection
1.2.2 Freeze-dried powder
1.3 Applications of Rosuvastatin
1.3.1 Hospital use
1.3.2 Clinic
1.3.3 Others
1.4 Industry Chain Structure of Rosuvastatin
1.5 Industry Overview and Major Regions Status of Rosuvastatin
1.5.1 Industry Overview of Rosuvastatin
1.5.2 Global Major Regions Status of Rosuvastatin
1.6 Industry Policy Analysis of Rosuvastatin
1.7 Industry News Analysis of Rosuvastatin

2 Manufacturing Cost Structure Analysis of Rosuvastatin
2.1 Raw Material Suppliers and Price Analysis of Rosuvastatin
2.2 Equipment Suppliers and Price Analysis of Rosuvastatin
2.3 Labor Cost Analysis of Rosuvastatin
2.4 Other Costs Analysis of Rosuvastatin
2.5 Manufacturing Cost Structure Analysis of Rosuvastatin
2.6 Manufacturing Process Analysis of Rosuvastatin

3 Technical Data and Manufacturing Plants Analysis of Rosuvastatin
3.1 Capacity and Commercial Production Date of Global Rosuvastatin Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Rosuvastatin Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Rosuvastatin Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Rosuvastatin Major Manufacturers in 2015

4 Global Rosuvastatin Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Rosuvastatin Capacity and Growth Rate Analysis
4.2.2 2015 Rosuvastatin Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Rosuvastatin Sales and Growth Rate Analysis
4.3.2 2015 Rosuvastatin Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Rosuvastatin Sales Price
4.4.2 2015 Rosuvastatin Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Rosuvastatin Gross Margin
4.5.2 2015 Rosuvastatin Gross Margin Analysis (Company Segment)

5 Rosuvastatin Regional Market Analysis
5.1 USA Rosuvastatin Market Analysis
5.1.1 USA Rosuvastatin Market Overview
5.1.2 USA 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Rosuvastatin Sales Price Analysis
5.1.4 USA 2015 Rosuvastatin Market Share Analysis
5.2 China Rosuvastatin Market Analysis
5.2.1 China Rosuvastatin Market Overview
5.2.2 China 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Rosuvastatin Sales Price Analysis
5.2.4 China 2015 Rosuvastatin Market Share Analysis
5.3 UK Rosuvastatin Market Analysis
5.3.1 UK Rosuvastatin Market Overview
5.3.2 UK 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.3.3 UK 2011-2016E Rosuvastatin Sales Price Analysis
5.3.4 UK 2015 Rosuvastatin Market Share Analysis
5.4 France Rosuvastatin Market Analysis
5.4.1 France Rosuvastatin Market Overview
5.4.2 France 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.4.3 France 2011-2016E Rosuvastatin Sales Price Analysis
5.4.4 France 2015 Rosuvastatin Market Share Analysis
5.5 Switzerland Rosuvastatin Market Analysis
5.5.1 Switzerland Rosuvastatin Market Overview
5.5.2 Switzerland 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Switzerland 2011-2016E Rosuvastatin Sales Price Analysis
5.5.4 Switzerland 2015 Rosuvastatin Market Share Analysis
5.6 Japan Rosuvastatin Market Analysis
5.6.1 Japan Rosuvastatin Market Overview
5.6.2 Japan 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.6.3 Japan 2011-2016E Rosuvastatin Sales Price Analysis
5.6.4 Japan 2015 Rosuvastatin Market Share Analysis
5.7 Germany Rosuvastatin Market Analysis
5.7.1 Germany Rosuvastatin Market Overview
5.7.2 Germany 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.7.3 Germany 2011-2016E Rosuvastatin Sales Price Analysis
5.7.4 Germany 2015 Rosuvastatin Market Share Analysis
5.8 Canada Rosuvastatin Market Analysis
5.8.1 Canada Rosuvastatin Market Overview
5.8.2 Canada 2011-2016E Rosuvastatin Local Supply, Import, Export, Local Consumption Analysis
5.8.3 Canada 2011-2016E Rosuvastatin Sales Price Analysis
5.8.4 Canada 2015 Rosuvastatin Market Share Analysis

6 Global 2011-2016E Rosuvastatin Segment Market Analysis (by Type)
6.1 Global 2011-2016E Rosuvastatin Sales by Type
6.2 Different Types Rosuvastatin Product Interview Price Analysis
6.3 Different Types Rosuvastatin Product Driving Factors Analysis
6.3.1 Injection Rosuvastatin Growth Driving Factor Analysis
6.3.2 Freeze-dried powder Rosuvastatin Growth Driving Factor Analysis

7 Global 2011-2016E Rosuvastatin Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital use Rosuvastatin Growth Driving Factor Analysis
7.3.2 Clinic Rosuvastatin Growth Driving Factor Analysis
7.3.3 Others Rosuvastatin Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Rosuvastatin
8.1 Pfizer
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Pfizer 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Pfizer 2015 Rosuvastatin Business Region Distribution Analysis
8.2 Teva
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Teva 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Teva 2015 Rosuvastatin Business Region Distribution Analysis
8.3 AstraZeneca UK Limited
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 AstraZeneca UK Limited 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 AstraZeneca UK Limited 2015 Rosuvastatin Business Region Distribution Analysis
8.4 Novartis
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Novartis 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Novartis 2015 Rosuvastatin Business Region Distribution Analysis
8.5 Mylan
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Mylan 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Mylan 2015 Rosuvastatin Business Region Distribution Analysis
8.6 Squibb
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Squibb 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Squibb 2015 Rosuvastatin Business Region Distribution Analysis
8.7 Sandoz
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Sandoz 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Sandoz 2015 Rosuvastatin Business Region Distribution Analysis
8.8 Hikma Pharmaceuticals?
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Hikma Pharmaceuticals? 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Hikma Pharmaceuticals? 2015 Rosuvastatin Business Region Distribution Analysis
8.9 GSK
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 GSK 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 GSK 2015 Rosuvastatin Business Region Distribution Analysis
8.10 Johnlee Pharmaceuticals Pvt. Ltd
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Johnlee Pharmaceuticals Pvt. Ltd 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Johnlee Pharmaceuticals Pvt. Ltd 2015 Rosuvastatin Business Region Distribution Analysis
8.11 Glenmark
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Glenmark 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Glenmark 2015 Rosuvastatin Business Region Distribution Analysis
8.12 Abbott
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Abbott 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Abbott 2015 Rosuvastatin Business Region Distribution Analysis
8.13 Takeda
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Takeda 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Takeda 2015 Rosuvastatin Business Region Distribution Analysis
8.14 IPR Pharmaceuticals
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 IPR Pharmaceuticals 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 IPR Pharmaceuticals 2015 Rosuvastatin Business Region Distribution Analysis
8.15 Lunan Better Pharmaceutical Co., Ltd
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Lunan Better Pharmaceutical Co., Ltd 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Lunan Better Pharmaceutical Co., Ltd 2015 Rosuvastatin Business Region Distribution Analysis
8.16 Nanjing Chia Tai Tianqing
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Nanjing Chia Tai Tianqing 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Nanjing Chia Tai Tianqing 2015 Rosuvastatin Business Region Distribution Analysis
8.17 Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd.
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. 2015 Rosuvastatin Business Region Distribution Analysis
8.18 Zhejiang Jingxin Pharmaceutical
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Zhejiang Jingxin Pharmaceutical 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Zhejiang Jingxin Pharmaceutical 2015 Rosuvastatin Business Region Distribution Analysis
8.19 Zhejiang Haizheng
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 Zhejiang Haizheng 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 Zhejiang Haizheng 2015 Rosuvastatin Business Region Distribution Analysis
8.20 Hainan Tongyong Sanyang
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.3 Hainan Tongyong Sanyang 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 Hainan Tongyong Sanyang 2015 Rosuvastatin Business Region Distribution Analysis
8.21 Indian Biocon
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.3 Indian Biocon 2015 Rosuvastatin Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.21.4 Indian Biocon 2015 Rosuvastatin Business Region Distribution Analysis

9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Rosuvastatin Consumption Forecast
9.2.2 China 2016-2021 Rosuvastatin Consumption Forecast
9.2.3 UK 2016-2021 Rosuvastatin Consumption Forecast
9.2.4 France 2016-2021 Rosuvastatin Consumption Forecast
9.2.5 Switzerland 2016-2021 Rosuvastatin Consumption Forecast
9.2.6 Japan 2016-2021 Rosuvastatin Consumption Forecast
9.2.7 Germany 2016-2021 Rosuvastatin Consumption Forecast
9.2.8 Canada 2016-2021 Rosuvastatin Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)

10 Rosuvastatin Marketing Model Analysis
10.1 Rosuvastatin Regional Marketing Model Analysis
10.2 Rosuvastatin International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Rosuvastatin by Regions
10.4 Rosuvastatin Supply Chain Analysis

11 Consumers Analysis of Rosuvastatin
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 New Project Investment Feasibility Analysis of Rosuvastatin
12.1 New Project SWOT Analysis of Rosuvastatin
12.2 New Project Investment Feasibility Analysis of Rosuvastatin

13 Conclusion of the Global Rosuvastatin Market Professional Survey Report 2016

Enquiry About Report

Need More Information

SIMILAR MARKET STUDIES

Global Onychomycosis (Tinea Unguium) Drug Detailed Analysis Report 2017-2022

This report splits Onychomycosis (Tinea Unguium) Drug by Product Drug Form, by Product Usage Type. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. And this report mainly introduces volume and value market share by players, by regions, by product type, by consumers and ...

July 2017 | $3250 | View Details >>

2017-2022 Botulinum Toxins Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

This report studies the Botulinum Toxins market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Botulinum Toxins market by product type and applications/end industries. The global ...

July 2017 | $2960 | View Details >>

Global Phyto Squalane Market Research Report 2017

In this report, the global Phyto Squalane market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, ...

July 2017 | $2900 | View Details >>

Global Shark Squalane Market Research Report 2017

In this report, the global Shark Squalane market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, ...

July 2017 | $2900 | View Details >>

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

July 2017 | Price:$ 5370 | Pre Book Price:$ 5370

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system’s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

March 2017 | Price:$ 7695 | Pre Book Price:$ 7695

Radiopharmaceuticals Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Radiopharmaceutical is a radioactive pharmaceutical agent which is used diagnostic or therapeutic procedures. A radiopharmaceutical is made up of two components that are drug component and radioactive component. This radioactive ...

March 2017 | Price:$ 7695 | Pre Book Price:$ 7695

Pharmaceutical Excipients Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Pharmaceutical excipients are substances other than the pharmacologically active drug or prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. The ...

March 2017 | Price:$ 7695 | Pre Book Price:$ 7695

Over the Counter (OTC) & Diet Supplementary Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of ...

March 2017 | Price:$ 7695 | Pre Book Price:$ 7695

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

July 2017 | Price:$ 5370 | Pre Book Price:$ 5370